Esposito Pamela

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$7.65M

Insider Activity of Esposito Pamela

According to the SEC Form 4 filings, Esposito Pamela, being in a position of

  1. director at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 16000 shares for $774,266,
    over all time since 2024-09-17, has bought 0 shares, and sold 16000 shares for $774,266.

The largest sale of all time was on 2021-01-15 and amounted to 29273 shares of Replimune Group, Inc. for $1.28M.

Biography of Esposito Pamela

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Prismo
Buys
 $000
Sells
 $774,2662100

Comparison of Insiders on Amount of Buys and Sells

Prismo
Prismo
2024-12-02SaleKymera Therapeutics, Inc.
KYMR
director
2,500
0.0039%
$49.00$122,500-17.47%
2024-09-17SaleKymera Therapeutics, Inc.
KYMR
director
13,500
0.0216%
$48.28$651,766-8.99%
2023-09-12SaleReplimune Group, Inc.
REPL
Chief Business Officer
300
0.0005%
$20.00$6,000-54.46%
2023-09-11SaleReplimune Group, Inc.
REPL
Chief Business Officer
5,358
0.0092%
$20.01$107,214-55.86%
2023-08-22SaleReplimune Group, Inc.
REPL
Chief Business Officer
18,600
0.0315%
$20.01$372,186-56.41%
2023-08-11SaleReplimune Group, Inc.
REPL
Chief Business Officer
1,400
0.0024%
$20.00$28,000-56.32%
2023-07-10SaleReplimune Group, Inc.
REPL
Chief Business Officer
20,000
0.035%
$21.58$431,541-58.78%
2023-05-16SaleReplimune Group, Inc.
REPL
Chief Business Officer
5,966
0.01%
$18.05$107,686-39.05%
2022-12-09SaleReplimune Group, Inc.
REPL
Chief Business Officer
15,000
0.026%
$25.03$375,450-21.52%
2022-05-16SaleReplimune Group, Inc.
REPL
Chief Business Officer
3,507
0.0065%
$14.59$51,167+32.21%
2021-08-05SaleReplimune Group, Inc.
REPL
Chief Business Officer
25,800
0.0478%
$35.09$905,322-43.94%
2021-08-04SaleReplimune Group, Inc.
REPL
Chief Business Officer
4,200
0.0081%
$35.00$147,000-41.71%
2021-07-21SaleReplimune Group, Inc.
REPL
Chief Business Officer
12,538
0.0239%
$33.17$415,885-36.47%
2021-07-20SaleReplimune Group, Inc.
REPL
Chief Business Officer
4,862
0.0093%
$33.05$160,689-34.38%
2021-07-15SaleReplimune Group, Inc.
REPL
Chief Business Officer
4,600
0.0092%
$33.37$153,502-26.1%
2021-01-19SaleReplimune Group, Inc.
REPL
Chief Business Officer
5,727
0.0115%
$42.47$243,226-23.5%
2021-01-15SaleReplimune Group, Inc.
REPL
Chief Business Officer
29,273
0.0598%
$43.58$1.28M-24.31%
2021-01-14SaleReplimune Group, Inc.
REPL
Chief Business Officer
20,000
0.04%
$45.02$900,400-28.2%
2020-10-14SaleReplimune Group, Inc.
REPL
Chief Business Officer
32,000
0.0588%
$32.90$1.05M-3.39%
2020-08-31SaleReplimune Group, Inc.
REPL
Chief Business Officer
10,000
0.0118%
$14.03$140,300+29.85%
Total: 20
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD